AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $247 | -94.2% | 106 | -94.1% | 0.00% | – |
| Q2 2023 | $4,282 | -99.5% | 1,799 | -99.6% | 0.00% | – |
| Q1 2023 | $811,000 | +86360.6% | 441,025 | -10.6% | 0.00% | – |
| Q4 2022 | $938 | -99.9% | 493,509 | +11.5% | 0.00% | – |
| Q3 2022 | $947,000 | -46.6% | 442,550 | -29.4% | 0.00% | – |
| Q2 2022 | $1,773,000 | -46.8% | 626,519 | -21.6% | 0.00% | – |
| Q1 2022 | $3,334,000 | -24.6% | 799,558 | -6.1% | 0.00% | -100.0% |
| Q4 2021 | $4,419,000 | -50.1% | 851,544 | -37.0% | 0.00% | 0.0% |
| Q3 2021 | $8,851,000 | +77.5% | 1,351,355 | +79.9% | 0.00% | 0.0% |
| Q2 2021 | $4,986,000 | +56.9% | 750,964 | +35.5% | 0.00% | – |
| Q1 2021 | $3,177,000 | +39.8% | 554,369 | +118.0% | 0.00% | – |
| Q4 2020 | $2,273,000 | +6.0% | 254,260 | +42.3% | 0.00% | – |
| Q3 2020 | $2,144,000 | -5.0% | 178,634 | +26.9% | 0.00% | – |
| Q2 2020 | $2,256,000 | +271.1% | 140,755 | +38.7% | 0.00% | – |
| Q1 2020 | $608,000 | +20.6% | 101,447 | +165.5% | 0.00% | – |
| Q4 2019 | $504,000 | – | 38,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |